mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
neopeltolide |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.3 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.3 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.063 |
0.3 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.3 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
-0.063 |
0.3 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.051 |
0.3 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.3 |